Asset vs Stock Sale at $10M: Founder vs Buyer Negotiation

The $10 million exit is the meaningful threshold for asset-vs-stock decision analysis. Below this level, the structural differences exist but the absolute dollars are smaller. At $10M, the gap between the two structures routinely exceeds $1.5 million in after-tax proceeds — sometimes $3.5M+ when QSBS is in play. The founder cannot afford to leave this negotiation to lawyers without economic accountability. The dollar consequences are too large.

This post lays out the precise tax math at $10M, the structural alternatives that can bridge buyer and seller preferences, and the negotiating positions each side can defensibly take. The goal is to equip founders with the analytical framework to push back when the buyer's counsel reflexively requests an asset purchase agreement.

The core tax math at $10M

Consider a C-corporation selling for $10M. The corporation's aggregate asset basis is $500K. The founder's stock basis is $200K. The founder is married filing jointly with taxable income at the top federal bracket. Compare three scenarios.

Scenario A: Asset sale of the C-corporation

Under IRC section 1060, the purchase price is allocated across the acquired assets using the residual method:

• Corporate-level gain: $10,000,000 − $500,000 = $9,500,000
• Corporate tax at 21%: $1,995,000
• Remaining for distribution: $8,005,000
• Shareholder basis in stock: $200,000
• Shareholder gain on liquidation: $8,005,000 − $200,000 = $7,805,000
• Shareholder tax at 23.8% (20% LTCG + 3.8% NIIT): $1,857,590
• Total federal tax: $3,852,590
• Founder's after-tax proceeds: $6,147,410
• Effective combined rate: 38.5%

Scenario B: Stock sale of the C-corporation (no QSBS)

• Shareholder gain: $10,000,000 − $200,000 = $9,800,000
• Shareholder tax at 23.8%: $2,332,400
• Total federal tax: $2,332,400
• Founder's after-tax proceeds: $7,667,600
• Effective rate: 23.3%

Scenario C: Stock sale with QSBS exclusion under section 1202

• Shareholder gain: $9,800,000
• Section 1202 exclusion (greater of $10M or 10 × $200K = $2M): $9,800,000 (entire gain excluded, under $10M cap)
• Taxable gain: $0
• Federal tax: $0
• Founder's after-tax proceeds: $10,000,000
• Effective rate: 0%

The gap between scenarios

• Scenario A (asset sale) vs Scenario B (stock sale, no QSBS): $1,520,190 difference in after-tax proceeds
• Scenario A vs Scenario C (stock sale with QSBS): $3,852,590 difference
• Scenario B vs Scenario C: $2,332,400 difference (the QSBS benefit alone)

The buyer's economic benefit from the asset sale

The buyer's reciprocal benefit from the asset-sale structure is the present value of the depreciation and amortization deductions on the stepped-up asset basis. On the same $10M deal, assume the buyer allocates:

• $2M to tangible equipment, depreciated over 7-15 years
• $1M to inventory and receivables (recovered immediately or over short periods)
• $7M to goodwill and going-concern value (Class VII assets), amortized over 15 years under IRC section 197

The buyer's annual amortization on the $7M goodwill: approximately $467K per year for 15 years. At a 21% corporate tax rate, that's $98K per year of cash tax savings, present-valued at 8% discount: approximately $840K. Add the present value of equipment depreciation (roughly $400K) and the buyer's total present-value benefit from the step-up is approximately $1.2M-$1.3M.

The seller's tax cost from the asset sale (relative to stock sale): $1.52M to $3.85M depending on QSBS status. The seller's loss often exceeds the buyer's gain — meaning the combined economic value is HIGHER under a stock sale than an asset sale. The wedge between the two structures is not a fixed cost; it is a fixed dead-weight loss that can be eliminated by choosing the stock structure.

Section 338(h)(10): the S-corp solution that doesn't help C-corps

IRC section 338(h)(10) allows a buyer and seller to jointly elect to treat a stock sale as a deemed asset sale for federal tax purposes. The election is available for:

• Targets that are S-corporations
• Targets that are members of a consolidated group (parent-subsidiary structures)

It is NOT available for standalone C-corporations. For a C-corp founder facing the asset-vs-stock decision, 338(h)(10) is not a structural option.

For S-corp targets, the election provides an elegant solution. The buyer acquires the stock but is treated as having acquired the assets at fair market value. The buyer gets the stepped-up basis. The seller — because S-corps are pass-through entities — recognizes gain as if the assets were sold, but the gain flows through to the shareholder at a single level of tax. There is no corporate-level tax (S-corps don't pay federal income tax), and the shareholder pays capital gains rates on the deemed asset sale. Buyer gets asset treatment; seller gets stock-sale economics.

The catch for S-corps: the deemed asset sale produces character recharacterization. Gain allocated to inventory, accounts receivable, or depreciation recapture under IRC section 1245 is ordinary income to the shareholder — not capital gain. The shareholder's tax rate on the ordinary portion can be 37% (top federal bracket) instead of 23.8%. The allocation under section 1060 thus becomes a sub-negotiation within the 338(h)(10) deal. For typical mid-market deals where goodwill is the dominant asset class, the recharacterization is manageable; for asset-heavy targets, it can materially shift the math.

Why C-corp founders face the structural impasse

For a standalone C-corporation, the buyer and seller preferences are genuinely incompatible:

• The buyer wants the asset-sale step-up — generating $1.2M-$1.3M in PV deductions on a $10M deal.
• The seller wants the stock-sale single layer of tax — saving $1.52M-$3.85M relative to an asset sale.
• The structural difference is not split-able through 338(h)(10) because the election is not available for standalone C-corps.

The resolution mechanisms for C-corp deals:

1. Negotiate a stock sale with purchase price adjustment

If the seller's tax cost from an asset sale exceeds the buyer's benefit, both parties can be better off under a stock sale with a modest purchase price reduction to compensate the buyer for the lost step-up. On the $10M deal above, if the seller reduces the price to $8.7M and structures as a stock sale, both sides are improved:

• Buyer pays $8.7M instead of $10M (saves $1.3M; loses $1.3M PV benefit from step-up; net zero)
• Seller (Scenario B, no QSBS): gain $8.5M, tax $2.02M, net $6.68M (worse than $7.67M stock sale but BETTER than the asset-sale Scenario A net of $6.15M)
• Seller with QSBS: gain $8.5M, fully excluded under section 1202, net $8.7M (worse than $10M stock-sale Scenario C but BETTER than asset-sale Scenario A)

The deal mechanics: the buyer accepts $1.3M less price in exchange for getting a stock sale, which they would have preferred to avoid. The seller accepts $1.3M less price in exchange for stock-sale tax treatment, which provides $1.52M-$3.85M of tax savings. Both sides benefit from the price reduction relative to the asset-sale baseline.

2. Negotiate a stock sale with structural concessions

The seller can offer non-price concessions to compensate the buyer for the lost step-up:

• Extended representations and warranties survival period
• Larger indemnification cap
• Larger or longer-tail escrow holdback
• Tax warranty protections (specifically warranting the QSBS qualification or other tax positions)
• Founder-employed transition periods with reduced or no compensation
• Restrictive covenants (non-compete, non-solicit) with extended duration

For some buyers, the risk-allocation benefits of these concessions exceed the present-value loss from no step-up. This is more common in transactions where the buyer's primary concern is operational continuity rather than tax economics.

3. F-reorganization to convert C-corp to S-corp before exit

For long-runway deals (12+ months before LOI), a pre-sale conversion from C-corp to S-corp via F-reorganization can enable a 338(h)(10) election at exit. The conversion creates S-corp character before sale, the buyer and seller execute the stock sale with 338(h)(10) election, and both sides get their preferred treatment.

The catch: C-corp to S-corp conversion creates a built-in gain (BIG) tax exposure under IRC section 1374 for 5 years post-conversion. If the company sells within 5 years of the S-election, the built-in gain at conversion is subject to corporate-level tax — partially restoring the double-tax problem the conversion was designed to avoid. For deals more than 5 years out, the F-reorg-to-S-corp strategy is fully effective. For deals within 5 years, the BIG tax limits the benefit.

The QSBS dimension: why stock sales matter more for qualifying founders

For founders whose stock qualifies as QSBS under IRC section 1202, the asset-vs-stock decision is not close. The section 1202 exclusion — up to $10 million of federal tax-free gain — applies ONLY to stock sales. An asset sale forfeits the entire exclusion.

On the $10M exit example:

• QSBS-eligible stock sale: $0 federal tax (Scenario C)
• Asset sale (forfeiting QSBS): $3.85M federal tax (Scenario A)
• Net difference: $3.85M of federal tax savings preserved by the stock structure

For QSBS-eligible founders, the structural argument for stock sales is overwhelming. The buyer's present-value benefit from the step-up ($1.3M) is less than half of the founder's QSBS savings. The negotiating posture for QSBS founders: stock sale or no deal — combined with a willingness to accept modest price concessions ($500K-$1M) to compensate the buyer for the lost step-up.

Worked negotiating scenarios at $10M

Scenario: QSBS-eligible founder vs strategic buyer

A founder with $9.8M of QSBS gain (after $200K basis) is negotiating with a strategic acquirer. The buyer's initial position: asset sale at $10M. The founder's counter:

• Stock sale at $10M: founder keeps $10M (zero federal tax due to QSBS), buyer loses $1.3M of PV step-up benefit
• Stock sale at $9M with QSBS: founder keeps $9M ($800K still under $10M QSBS cap, zero federal tax), buyer effectively pays $1M less than original offer and loses $1.3M of step-up
• Compromise: stock sale at $9.4M. Founder keeps $9.4M (all federally excluded), buyer pays $600K less than original offer and gives up $1.3M of step-up
• Buyer net cost: ($600K price reduction) + ($1.3M step-up loss) = $1.9M relative to asset sale at $10M
• Founder net gain: $9.4M − $6.15M (Scenario A net) = $3.25M relative to asset sale at $10M

Both sides better off under the compromise. The combined value creation: $3.25M (founder gain) − $1.9M (buyer cost) = $1.35M of net value compared to the asset-sale baseline. This is the value that QSBS treatment creates, and it can be split through deal terms.

Scenario: Non-QSBS founder vs financial buyer

A founder with $9.8M of non-QSBS gain (basis $200K) is negotiating with a private equity buyer. The founder's tax differential between asset and stock structures is $1.52M (Scenario A vs B). The buyer's PV benefit from step-up is $1.3M.

• Stock sale at $10M: founder keeps $7.67M, buyer loses $1.3M of step-up
• Asset sale at $10M: founder keeps $6.15M, buyer captures $1.3M of step-up
• Compromise: stock sale at $9.4M with founder paying small tax-loss adjustment to buyer. Founder keeps $9.4M − $9.4M*23.8% on $9.2M of gain = $9.4M − $2.19M = $7.21M. Buyer effectively pays $600K less than original asset-sale offer.
• Founder slightly worse than $7.67M stock sale at $10M but much better than $6.15M asset sale
• Buyer slightly worse than $1.3M step-up but better than zero step-up on a $10M stock sale

For non-QSBS deals, the negotiating room is smaller. The compromise is usually a modest price adjustment rather than a structural change.

Liability allocation: the non-tax driver of asset preference

Asset sales also provide buyer liability isolation. Only the liabilities explicitly assumed by the buyer transfer; the rest stay with the selling entity (which the founder may eventually liquidate after the asset sale). For buyers concerned about unknown or contingent liabilities (pending litigation, tax positions, environmental issues, employment claims), the asset structure provides clean separation.

The seller's counter: representations, warranties, indemnification, and escrow holdbacks can provide liability isolation in a stock sale without forfeiting the tax benefits. The buyer is protected against pre-closing liabilities through the seller's contractual obligations. The mechanism is litigation-prone if disputes arise, but it functionally addresses the buyer's liability concerns without the structural asset sale.

Sellers offering robust rep-and-warranty packages — survival of fundamental reps through statute of limitations, large escrow holdbacks, broad indemnification — can often overcome the buyer's liability-based preference for asset structure.

What the founder should do before LOI

• Confirm QSBS qualification with tax counsel. If QSBS applies, the structural argument for stock sale is overwhelming. Tax counsel's written opinion strengthens the negotiating position.
• Model both scenarios with after-tax dollar figures. The founder's tax differential should be calculated in advance, not estimated during negotiation. Knowing the precise dollar gap arms the founder for the price-adjustment discussion.
• Identify which assets are large step-up beneficiaries. For asset-heavy targets (equipment, real estate), the buyer's PV benefit is larger than for goodwill-heavy targets. The size of the buyer's economic benefit determines how much price adjustment is reasonable.
• Consider 338(h)(10) eligibility. If the company is an S-corp (or could become one via F-reorg in time), 338(h)(10) is the bridge structure. C-corp founders without this option face a harder negotiation.
• Prepare alternative liability-isolation mechanisms. Robust representations, warranties, escrows, and indemnification can address buyer liability concerns without resorting to asset structure.
• Engage M&A counsel early. The asset-vs-stock decision is shaped in the LOI. By the time the definitive agreement is being drafted, the structural choice is usually settled. Influence the LOI before signing.

What the founder should NOT do

• Agree to an asset sale because the buyer's counsel says it's standard.
• Accept that "the tax difference is small" without running the actual numbers.
• Trust that the buyer will compensate for the tax differential without a contractual price adjustment.
• Sign an LOI that pre-commits to asset structure without negotiating it.
• Forfeit QSBS treatment without understanding the dollar value.

Key takeaways

• On a $10M C-corp exit, the asset-vs-stock structural difference exceeds $1.5M in after-tax proceeds even without QSBS. With QSBS, the differential exceeds $3.8M — the entire $10M exclusion is at stake.
• The C-corp double-tax problem under asset sales produces effective combined rates approaching 39% — corporate tax (21%) plus shareholder tax on liquidation (23.8%). Stock sales limit federal tax to a single 23.8% layer.
• Section 338(h)(10) bridges buyer and seller preferences for S-corp and consolidated-subsidiary targets but is not available for standalone C-corps.
• For QSBS-eligible founders, the stock-sale argument is overwhelming. The buyer's present-value benefit from step-up ($1.2M-$1.3M on $10M deals) is far less than the founder's QSBS savings ($2.4M-$3.85M). Combined value is maximized under stock structure.
• Price adjustments and structural concessions can bridge the gap between buyer and seller preferences. A modest price reduction ($500K-$1M on a $10M deal) often leaves both parties better off than under an asset sale at full price.
• Liability isolation, the non-tax driver of buyer preference for asset structure, can be addressed through robust representations, warranties, escrows, and indemnification in a stock-sale framework.
• The structural decision must be made at LOI stage. Asset-vs-stock is the highest-leverage negotiation in the entire deal and should not be left to the definitive-agreement drafting phase.